Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Oxybenzone Alters Mammary Gland Morphology in Mice Exposed During Pregnancy and Lactation.

LaPlante CD, Bansal R, Dunphy KA, Jerry DJ, Vandenberg LN.

J Endocr Soc. 2018 May 22;2(8):903-921. doi: 10.1210/js.2018-00024. eCollection 2018 Aug 1.

2.

Genetic variation in sensitivity to estrogens and breast cancer risk.

Jerry DJ, Shull JD, Hadsell DL, Rijnkels M, Dunphy KA, Schneider SS, Vandenberg LN, Majhi PD, Byrne C, Trentham-Dietz A.

Mamm Genome. 2018 Feb;29(1-2):24-37. doi: 10.1007/s00335-018-9741-z. Epub 2018 Feb 27.

3.

Cancer Cell Discrimination Using Host-Guest "Doubled" Arrays.

Le NDB, Yesilbag Tonga G, Mout R, Kim ST, Wille ME, Rana S, Dunphy KA, Jerry DJ, Yazdani M, Ramanathan R, Rotello CM, Rotello VM.

J Am Chem Soc. 2017 Jun 14;139(23):8008-8012. doi: 10.1021/jacs.7b03657. Epub 2017 Jun 1.

4.

Individual-specific variation in the respiratory activities of HMECs and their bioenergetic response to IGF1 and TNFα.

Schneider SS, Henchey EM, Sultana N, Morin SM, Jerry DJ, Makari-Judson G, Crisi GM, Arenas RB, Johnson M, Mason HS, Yadava N.

J Cell Physiol. 2017 Oct;232(10):2750-2765. doi: 10.1002/jcp.25932. Epub 2017 May 15.

5.

Use of p53-Silenced Endothelial Progenitor Cells to Treat Ischemia in Diabetic Peripheral Vascular Disease.

Kundu N, Domingues CC, Chou C, Ahmadi N, Houston S, Jerry DJ, Sen S.

J Am Heart Assoc. 2017 Apr 1;6(4). pii: e005146. doi: 10.1161/JAHA.116.005146.

6.

Prostate tumorigenesis induced by PTEN deletion involves estrogen receptor β repression.

Mak P, Li J, Samanta S, Chang C, Jerry DJ, Davis RJ, Leav I, Mercurio AM.

Cell Rep. 2015 Mar 31;10(12):1982-91. doi: 10.1016/j.celrep.2015.02.063. Epub 2015 Mar 26. Erratum in: Cell Rep. 2015 May 19;11(7):1147-9.

7.

Weight gain following breast cancer diagnosis: Implication and proposed mechanisms.

Makari-Judson G, Braun B, Jerry DJ, Mertens WC.

World J Clin Oncol. 2014 Aug 10;5(3):272-82. doi: 10.5306/wjco.v5.i3.272. Review.

8.

Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status.

Rotunno M, Sun X, Figueroa J, Sherman ME, Garcia-Closas M, Meltzer P, Williams T, Schneider SS, Jerry DJ, Yang XR, Troester MA.

Breast Cancer Res. 2014 Jul 8;16(4):R74. doi: 10.1186/bcr3689.

9.

DNA methylation in paired breast epithelial and white blood cells from women undergoing reduction mammoplasty.

Sturgeon SR, Arcaro KF, Johnson MA, Balasubramanian R, Zorn M, Jerry DJ, Schneider SS.

Anticancer Res. 2014 Jun;34(6):2985-90.

PMID:
24922663
10.

Pregnancy offers new insights into mechanisms of breast cancer risk and resistance.

Jerry DJ, Makari-Judson G, Crisi GM, Dunphy KA.

Breast Cancer Res. 2013;15(5):312.

11.

A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cells.

Petrocca F, Altschuler G, Tan SM, Mendillo ML, Yan H, Jerry DJ, Kung AL, Hide W, Ince TA, Lieberman J.

Cancer Cell. 2013 Aug 12;24(2):182-96. doi: 10.1016/j.ccr.2013.07.008.

12.

Oncogenic transformation of mammary epithelial cells by transforming growth factor beta independent of mammary stem cell regulation.

Dunphy KA, Seo JH, Kim DJ, Roberts AL, Tao L, DiRenzo J, Balboni AL, Crisi GM, Hagen MJ, Chandrasekaran T, Gauger KJ, Schneider SS, Jerry DJ.

Cancer Cell Int. 2013 Jul 25;13:74. doi: 10.1186/1475-2867-13-74. eCollection 2013.

13.

MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transition.

DeCastro AJ, Dunphy KA, Hutchinson J, Balboni AL, Cherukuri P, Jerry DJ, DiRenzo J.

Cell Death Dis. 2013 Feb 28;4:e514. doi: 10.1038/cddis.2013.37.

14.

siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/- with susceptibility versus C57BL/6-Trp53+/- mice with resistance to mammary tumors.

Böhringer M, Obermeier K, Griner N, Waldraff D, Dickinson E, Eirich K, Schindler D, Hagen M, Jerry DJ, Wiesmüller L.

Oncogene. 2013 Nov 28;32(48):5458-70. doi: 10.1038/onc.2013.38. Epub 2013 Feb 25.

15.

Impaired mitochondrial metabolism and mammary carcinogenesis.

Yadava N, Schneider SS, Jerry DJ, Kim C.

J Mammary Gland Biol Neoplasia. 2013 Mar;18(1):75-87. doi: 10.1007/s10911-012-9271-3. Epub 2012 Dec 27. Review.

16.

Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer.

Pirone JR, D'Arcy M, Stewart DA, Hines WC, Johnson M, Gould MN, Yaswen P, Jerry DJ, Smith Schneider S, Troester MA.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1735-44. doi: 10.1158/1055-9965.EPI-12-0451. Epub 2012 Aug 2.

17.

Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type.

Nguyen DH, Oketch-Rabah HA, Illa-Bochaca I, Geyer FC, Reis-Filho JS, Mao JH, Ravani SA, Zavadil J, Borowsky AD, Jerry DJ, Dunphy KA, Seo JH, Haslam S, Medina D, Barcellos-Hoff MH.

Cancer Cell. 2011 May 17;19(5):640-51. doi: 10.1016/j.ccr.2011.03.011.

18.

Mitochondrial dysfunction impairs tumor suppressor p53 expression/function.

Compton S, Kim C, Griner NB, Potluri P, Scheffler IE, Sen S, Jerry DJ, Schneider S, Yadava N.

J Biol Chem. 2011 Jun 10;286(23):20297-312. doi: 10.1074/jbc.M110.163063. Epub 2011 Apr 18.

19.

The role of activin in mammary gland development and oncogenesis.

Dunphy KA, Schneyer AL, Hagen MJ, Jerry DJ.

J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):117-26. doi: 10.1007/s10911-011-9214-4. Epub 2011 Apr 8. Review.

PMID:
21475961
20.

Map making in the 21st century: charting breast cancer susceptibility pathways in rodent models.

Blackburn AC, Jerry DJ.

J Mammary Gland Biol Neoplasia. 2011 Apr;16(1):57-64. doi: 10.1007/s10911-011-9201-9. Epub 2011 Mar 8.

21.

Repression of mammary stem/progenitor cells by p53 is mediated by Notch and separable from apoptotic activity.

Tao L, Roberts AL, Dunphy KA, Bigelow C, Yan H, Jerry DJ.

Stem Cells. 2011 Jan;29(1):119-27. doi: 10.1002/stem.552.

22.

Role of JNK in a Trp53-dependent mouse model of breast cancer.

Cellurale C, Weston CR, Reilly J, Garlick DS, Jerry DJ, Sluss HK, Davis RJ.

PLoS One. 2010 Aug 30;5(8):e12469. doi: 10.1371/journal.pone.0012469.

23.

Mammary epithelial transplant procedure.

Dunphy KA, Tao L, Jerry DJ.

J Vis Exp. 2010 Jun 10;(40). pii: 1849. doi: 10.3791/1849.

24.

Estrogens, regulation of p53 and breast cancer risk: a balancing act.

Jerry DJ, Dunphy KA, Hagen MJ.

Cell Mol Life Sci. 2010 Apr;67(7):1017-23. Review.

PMID:
20238478
25.

Pathways contributing to development of spontaneous mammary tumors in BALB/c-Trp53+/- mice.

Yan H, Blackburn AC, McLary SC, Tao L, Roberts AL, Xavier EA, Dickinson ES, Seo JH, Arenas RB, Otis CN, Cao QJ, Lawlor RG, Osborne BA, Kittrell FS, Medina D, Jerry DJ.

Am J Pathol. 2010 Mar;176(3):1421-32. doi: 10.2353/ajpath.2010.090438. Epub 2010 Jan 28.

26.

Array-based sensing of normal, cancerous, and metastatic cells using conjugated fluorescent polymers.

Bajaj A, Miranda OR, Phillips R, Kim IB, Jerry DJ, Bunz UH, Rotello VM.

J Am Chem Soc. 2010 Jan 27;132(3):1018-22. doi: 10.1021/ja9061272.

27.

Activation of host wound responses in breast cancer microenvironment.

Troester MA, Lee MH, Carter M, Fan C, Cowan DW, Perez ER, Pirone JR, Perou CM, Jerry DJ, Schneider SS.

Clin Cancer Res. 2009 Nov 15;15(22):7020-8. doi: 10.1158/1078-0432.CCR-09-1126. Epub 2009 Nov 3.

28.

Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity.

Tchatchou S, Riedel A, Lyer S, Schmutzhard J, Strobel-Freidekind O, Gronert-Sum S, Mietag C, D'Amato M, Schlehe B, Hemminki K, Sutter C, Ditsch N, Blackburn A, Hill LZ, Jerry DJ, Bugert P, Weber BH, Niederacher D, Arnold N, Varon-Mateeva R, Wappenschmidt B, Schmutzler RK, Engel C, Meindl A, Bartram CR, Mollenhauer J, Burwinkel B.

Hum Mutat. 2010 Jan;31(1):60-6. doi: 10.1002/humu.21134.

PMID:
19830809
29.

Virus-inspired approach to nonviral gene delivery vehicles.

Roy R, Jerry DJ, Thayumanavan S.

Biomacromolecules. 2009 Aug 10;10(8):2189-93. doi: 10.1021/bm900370p.

30.

Detection and differentiation of normal, cancerous, and metastatic cells using nanoparticle-polymer sensor arrays.

Bajaj A, Miranda OR, Kim IB, Phillips RL, Jerry DJ, Bunz UH, Rotello VM.

Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):10912-6. doi: 10.1073/pnas.0900975106. Epub 2009 Jun 23.

31.

Protein-passivated Fe(3)O(4) nanoparticles: low toxicity and rapid heating for thermal therapy.

Samanta B, Yan H, Fischer NO, Shi J, Jerry DJ, Rotello VM.

J Mater Chem. 2008;18(11):1204-1208.

32.

Regulation of cancer stem cells by p53.

Jerry DJ, Tao L, Yan H.

Breast Cancer Res. 2008;10(4):304. doi: 10.1186/bcr2133. Epub 2008 Aug 29.

33.

Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity.

Lu S, Becker KA, Hagen MJ, Yan H, Roberts AL, Mathews LA, Schneider SS, Siegelmann HT, MacBeth KJ, Tirrell SM, Blanchard JL, Jerry DJ.

Endocrinology. 2008 Oct;149(10):4809-20. doi: 10.1210/en.2008-0035. Epub 2008 Jun 12.

34.

Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/- mice.

Dunphy KA, Blackburn AC, Yan H, O'Connell LR, Jerry DJ.

Breast Cancer Res. 2008;10(3):R43. doi: 10.1186/bcr2094. Epub 2008 May 12.

35.

Mammary tumor modifiers in BALB/cJ mice heterozygous for p53.

Koch JG, Gu X, Han Y, El-Naggar AK, Olson MV, Medina D, Jerry DJ, Blackburn AC, Peltz G, Amos CI, Lozano G.

Mamm Genome. 2007 May;18(5):300-9. Epub 2007 Jun 8.

PMID:
17557176
36.

Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk.

Blackburn AC, Hill LZ, Roberts AL, Wang J, Aud D, Jung J, Nikolcheva T, Allard J, Peltz G, Otis CN, Cao QJ, Ricketts RS, Naber SP, Mollenhauer J, Poustka A, Malamud D, Jerry DJ.

Am J Pathol. 2007 Jun;170(6):2030-41.

37.
38.

Sensitivity to DNA damage is a common component of hormone-based strategies for protection of the mammary gland.

Tu Y, Jerry DJ, Pazik B, Smith Schneider S.

Mol Cancer Res. 2005 Aug;3(8):435-42.

39.

Estrogen and progesterone regulate radiation-induced p53 activity in mammary epithelium through TGF-beta-dependent pathways.

Becker KA, Lu S, Dickinson ES, Dunphy KA, Mathews L, Schneider SS, Jerry DJ.

Oncogene. 2005 Sep 22;24(42):6345-53.

PMID:
15940247
40.

Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.

Blackburn AC, McLary SC, Naeem R, Luszcz J, Stockton DW, Donehower LA, Mohammed M, Mailhes JB, Soferr T, Naber SP, Otis CN, Jerry DJ.

Cancer Res. 2004 Aug 1;64(15):5140-7.

41.

BALB/c alleles for Prkdc and Cdkn2a interact to modify tumor susceptibility in Trp53+/- mice.

Blackburn AC, Brown JS, Naber SP, Otis CN, Wood JT, Jerry DJ.

Cancer Res. 2003 May 15;63(10):2364-8.

42.

Regulation of apoptosis during mammary involution by the p53 tumor suppressor gene.

Jerry DJ, Dickinson ES, Roberts AL, Said TK.

J Dairy Sci. 2002 May;85(5):1103-10. Review.

PMID:
12086044
43.

Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?

Blackburn AC, Jerry DJ.

Breast Cancer Res. 2002;4(3):101-11. Epub 2002 Apr 18. Review.

44.

Hormonal control of p53 and chemoprevention.

Jerry DJ, Minter LM, Becker KA, Blackburn AC.

Breast Cancer Res. 2002;4(3):91-4. Epub 2002 Mar 26. Review.

45.

Epithelial cell cycling predicts p53 responsiveness to gamma-irradiation during post-natal mammary gland development.

Minter LM, Dickinson ES, Naber SP, Jerry DJ.

Development. 2002 Jun;129(12):2997-3008.

46.

Production of calves from G1 fibroblasts.

Kasinathan P, Knott JG, Wang Z, Jerry DJ, Robl JM.

Nat Biotechnol. 2001 Dec;19(12):1176-8.

PMID:
11731789
47.

Effect of fibroblast donor cell age and cell cycle on development of bovine nuclear transfer embryos in vitro.

Kasinathan P, Knott JG, Moreira PN, Burnside AS, Jerry DJ, Robl JM.

Biol Reprod. 2001 May;64(5):1487-93.

PMID:
11319156
48.

Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.

Kuperwasser C, Hurlbut GD, Kittrell FS, Dickinson ES, Laucirica R, Medina D, Naber SP, Jerry DJ.

Am J Pathol. 2000 Dec;157(6):2151-9.

49.

Cytoplasmic sequestration and functional repression of p53 in the mammary epithelium is reversed by hormonal treatment.

Kuperwasser C, Pinkas J, Hurlbut GD, Naber SP, Jerry DJ.

Cancer Res. 2000 May 15;60(10):2723-9.

50.

A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.

Jerry DJ, Kittrell FS, Kuperwasser C, Laucirica R, Dickinson ES, Bonilla PJ, Butel JS, Medina D.

Oncogene. 2000 Feb 21;19(8):1052-8.

Supplemental Content

Loading ...
Support Center